We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Study Points to Metabolic Approach to Treating Neurodegenerative Diseases
News

Study Points to Metabolic Approach to Treating Neurodegenerative Diseases

Study Points to Metabolic Approach to Treating Neurodegenerative Diseases
News

Study Points to Metabolic Approach to Treating Neurodegenerative Diseases

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Study Points to Metabolic Approach to Treating Neurodegenerative Diseases"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

In doing so, however, the undamaged optic nerve becomes vulnerable to further metabolic stress, which could explain why the neurodegeneration observed in this and other diseases spreads between brain regions.

“This is the first demonstration of metabolic resources being shared between the two eyes and optic nerves,” said David Calkins, PhD, vice chair of the Department of Ophthalmology and Visual Sciences at VUMC and director of the Vanderbilt Vision Research Center.

The report by Calkins and colleagues, published in the Proceedings of the National Academy of Sciences, suggests a potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease by beefing up the metabolic resources of the involved neurons.

Glaucoma, a leading cause of blindness, is caused by sensitivity to ocular pressure, which leads to degeneration of the eye’s neural projection to the brain.

Crucial to neuronal health are astrocytes, the star-shaped glial cells that store glycogen and release it as glucose, the fuel that neurons need to function since they do not store their own energy source.

Using positron emission tomography (PET) imaging, which can map the metabolic activity of cells in different tissues, the researchers showed that when one optic nerve was stressed by a rise in intraocular pressure, metabolites including glycogen were transferred from the healthy optic nerve via their crossover point in the brain.

“The energy is transferred up one optic nerve, across the optic chiasm (an X-shaped structure formed by the crossing of the optic nerves) in the brain and back down to the other eye, which is a tremendous distance for metabolites to travel,” Calkins said.

“We don’t know exactly how it’s done,” he said.

However, the transfer is dependent on connexin 43 (Cx43), the protein that makes up the gap junctions in astrocytes. Gap junctions are intracellular channels that connect adjacent cells and which permit the exchange of small molecules between them.

When Cx43 was genetically “knocked out” in a mouse model, the energy transfer didn’t happen within the astrocyte networks between the two optic nerves.

The transfer phenomenon helps explain the bilateral effects seen in neurodegenerative diseases. Alzheimer’s disease, for example, can start in one hemisphere of the brain and travel to the next.

While sharing energy helps the diseased tissue, the tissue that’s donating its energy stores becomes more susceptible to subsequent injury. “There’s a price to be paid,” Calkins said.

“This implies that a way to slow neurodegeneration generally would be to boost metabolic resources in the brain,” he said. “One way that can be done is by targeting astrocytes to reprogram them to create and store more metabolites to share with neurons.”

Using gene therapy to reprogram neurons in certain diseases of the visual system has been shown to be effective. “What I’m trying to do now is through gene therapy to reprogram astrocytes by using viruses to insert genes into their DNA,” he said.

Reference


Cooper et al. (2020). Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress. PNAS. DOI: https://doi.org/10.1073/pnas.2009425117

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement